[NVAX]
Mid
Mid
2026-08-28 22:31:31
Novavax announces regulatory approvals for updated COVID shot
Mid
2026-08-07 07:29:25
Novavax expects $235M-$275M in 2026 adjusted total revenue while targeting $150M-$200M in 2028 non-GAAP R&D and SG&A
Mid
2026-08-06 21:46:59
Earnings Snapshot: Novavax beats Q2 top and bottom line estimates; raises FY26 adjusted total revenue outlook
Mid
2026-07-11 01:48:11
Novavax options trading jumps to highest in months